A carregar...

Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.

Magnetic resonance-based measures of disease activity and progression are now routinely used in definitive phase III treatment trials of multiple sclerosis as important secondary outcome measures because they provide quantitative and objective confirmation of the primary clinical outcome measures. M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Simon, J H
Formato: Artigo
Idioma:Inglês
Publicado em: 1996
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1303626/
https://ncbi.nlm.nih.gov/pubmed/8764625
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!